Moderna, Inc. (BIT:1MRNA)

Market Cap	13.79B -16.9%
Revenue (ttm)	1.90B -56.1%
Net Income	-2.66B
EPS	-6.86
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,465
Average Volume	25,473
Open	35.35
Previous Close	34.85
Day's Range	35.23 - 38.23
52-Week Range	19.38 - 47.00
Beta	n/a
RSI	56.75
Earnings Date	Feb 13, 2026

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 5,800
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1MRNA

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD